Skip to main content
. Author manuscript; available in PMC: 2016 Mar 7.
Published in final edited form as: Drug News Perspect. 2010 May;23(4):229–240. doi: 10.1358/dnp.2010.23.4.1416977

Figure 1.

Figure 1

Schematic Illustration of the structures and effector systems of the muscarinic acetylcholine (ACh) receptor subtypes M1–M5. The orthosteric binding domain (OBD) is highlighted within the transmembrane domain and putative allosteric binding sites are denoted. PLC, phospholipase C; AC, adenylyl cyclase.